Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer
The efficiencies of T cell based immunotherapies are affected by insufficient migration and activation of tumor specific effector T cells in the tumor. Accumulating evidence exists on the ability of ionizing radiation to modify the tumor microenvironment and generate inflammation. The aim of this ph...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Article (Journal) |
| Lenguaje: | inglés |
| Publicado: |
13 April 2011
|
| In: |
BMC cancer
Year: 2011, Volumen: 11, Pages: 1-7 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/1471-2407-11-134 |
| Acceso en línea: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-11-134 |
| Notas de Autor: | Carmen Timke, Hubertus Schmitz Winnenthal, Felix Klug, Falk FF Roeder, Andreas Bonertz, Christoph Reissfelder, Nathalie Rochet, Moritz Koch, Christine Tjaden, Markus W Buechler, Juergen Debus, Jens Werner, Philipp Beckhove, Jürgen Weitz and Peter E Huber |
| Sumario: | The efficiencies of T cell based immunotherapies are affected by insufficient migration and activation of tumor specific effector T cells in the tumor. Accumulating evidence exists on the ability of ionizing radiation to modify the tumor microenvironment and generate inflammation. The aim of this phase I/II clinical trial is to evaluate whether low dose single fraction radiotherapy can improve T cell associated antitumor immune response in patients with pancreatic cancer. |
|---|---|
| Notas: | Gesehen am 03.11.2022 |
| Descripción Física: | Online Resource |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/1471-2407-11-134 |